文献速递头颈外科鼻科耳科与耳神经

耳鼻咽喉科患者静脉血栓栓塞预防新方案的实施

Implementation of a Novel Protocol for Preventing Venous Thromboembolism in Otolaryngology Patients.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-07-13

本研究基于Caprini风险评估模型(CRAM)制定了一套减少术后抗凝的改良方案,用于耳鼻咽喉头颈外科手术患者。共纳入508例患者,方案依从性79%,术后3个月内仅1例发生深静脉血栓,无肺栓塞,2例大出血与抗凝无关。结论认为该方案有效安全,但需更大规模研究验证。

要点

  • 基于CRAM的改良方案在耳鼻咽喉手术患者中依从性达79%。
  • 508例患者术后3个月内仅1例深静脉血栓,无肺栓塞。
  • 2例大出血与抗凝使用无关,方案安全性良好。

核心结论

  • 基于CRAM的新型方案在耳鼻咽喉科预防静脉血栓栓塞中显示有效且安全。

研究设计与样本

  • 观察性试点研究,纳入508例接受手术的耳鼻咽喉头颈外科患者,大学附属三级医疗中心开展。

主要发现

  • 48%患者接受头颈手术,18%直接喉镜及经口机器人手术,15%内镜鼻窦手术,11%耳科手术。
  • 方案依从性79%,平均随访115天(范围30-448天)。
  • 仅1例发生深静脉血栓,无肺栓塞;2例大出血与抗凝使用无关。

关键数值与推荐

  • 基于CRAM及耳鼻咽喉头颈外科文献构建改良方案,采用减少术后抗凝的策略。
  • 主要终点为术后3个月内有症状的静脉血栓栓塞,次要终点为术后出血。

临床怎么用

  • 该CRAM改良方案可用于耳鼻咽喉手术患者的静脉血栓栓塞预防,但需更大规模研究验证。

局限性

  • 观察性试点研究,样本量有限,需更大规模研究验证 findings。
  • 证据等级为Level 2b。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Venous thromboembolism (VTE) is a preventable cause of postoperative morbidity and mortality. The Caprini risk assessment model (CRAM) is a validated tool for estimating the risk for postoperative VTE. Previous studies demonstrated a low risk of VTE among otorhinolaryngology-head and neck surgery (ORL-HNS). Hence, our objective was to modify the CRAM-based protocol to be applicable for otolaryngology patients and assess protocol efficacy and safety. STUDY DESIGN: Observational pilot study conducted on ORL-HNS patients undergoing surgery. SETTING: University-affiliated tertiary care center. METHODS: We constructed a modified protocol based on the CRAM and previous reports in the ORL-HNS literature using a reduced postoperative anticoagulation regimen. Primary end point was symptomatic VTE up to 3 months after surgery. Main secondary outcome was postoperative bleeding. RESULTS: A total of 508 patients were enrolled. Of them, 48% underwent head and neck surgery, 18% direct laryngoscopy and transoral robotic surgery, 15% endoscopic sinus surgery, and 11% otology surgery. Adherence to the protocol was 79%. Mean follow-up time was 115 days (range, 30-448 days). Only 1 patient developed deep vein thrombosis, and none developed pulmonary embolism. Two patients had major bleeding not related to the use of anticoagulation. CONCLUSIONS: Our novel CRAM-based protocol appears to be efficacious and safe for VTE prevention in otolaryngology. A larger-scale study is required to validate these findings. LEVEL OF EVIDENCE: Level 2b.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Levi L, Spectre G, Nesichi O, et al. Implementation of a Novel Protocol for Preventing Venous Thromboembolism in Otolaryngology Patients. Otolaryngol Head Neck Surg. 2021. PMID: 34255600. doi:10.1177/01945998211024923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。